Please login to the form below

Not currently logged in
Email:
Password:

Dean Sowman joins Portland Health

He moves from MHP Communications to take up account director role

Portland Health Dean SowmanLondon-based communications agency Portland Health has appointed Dean Sowman as an account director.

He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.

Sowman said: “I am delighted to be joining Portland’s excellent and growing health team, and am really excited about helping our clients navigate this rapidly and substantially changing health landscape.”

Prior to his time at MHP he served as parliamentary and policy manager at ukactive, a UK trade body for the physical activity sector, where he led a national public health campaign that received the Public Affairs Award for ‘Trade Body Campaign of the Year’.

Partner and Head of Health Dr Jane Brearley said: “We are delighted to welcome Dean, who has the skills and charisma to complement Portland’s growing Health team. His wealth of experience in public affairs and healthcare communications will support and further develop the work we do for our clients.”

It’s the agency’s fifth senior hire in just over a year and Portland Health said that overall its health team had expanded by 30% during 2016.

10th March 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics